Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study.

Lau, Wallis CY; Douglas, Ian J; Wong, Ian CK; Smeeth, Liam; Lip, Gregory YH; Leung, Wai K; Siu, Chung-Wah; Cheung, Bernard MY; Mok, Michael TC; Chan, Esther W; (2019) Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study. Heart Rhythm, 17 (1). pp. 33-40. ISSN 1547-5271 DOI: https://doi.org/10.1016/j.hrthm.2019.07.034

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.hrthm.2019.07.034

Abstract

Share

Download

Embargo Date: 1 August 2020

Restricted to: Repository staff only

Filename: Thromboembolic-Bleeding-and-Mortality-Risks-among-Patients.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

[img]

Downloads

View details

Metrics & Citations


Google Scholar